Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Blood Protein Profile Indicates Early-Onset Coronary Heart Disease

By LabMedica International staff writers
Posted on 24 Nov 2025

People with a family history of early-onset coronary heart disease often face a higher risk despite normal cholesterol or blood pressure, and current screening tools don’t fully explain why. More...

Now, a new study reveals that a distinct pattern of circulating proteins may serve as early warning markers of hereditary atherosclerosis, offering a biological explanation for this elevated risk.

In the study, researchers at Karolinska Institutet (Stockholm, Sweden) analyzed blood samples from more than 4,000 individuals without diagnosed heart disease and linked them to documented cardiovascular histories of the participants’ parents and siblings. The study identified 38 proteins, many of them involved in inflammation and lipid metabolism, that were significantly more prevalent in individuals with a family history of cardiovascular disease.

The team measured protein levels and compared them with detailed clinical imaging and registry data. They drew on the large Swedish SCAPIS population study, which includes computed tomography of coronary arteries, and matched these results with family histories from the Swedish Multigenerational Register. Among people with hereditary risk, coronary atherosclerosis was more extensive, reflected by a greater number of diseased coronary segments. Some proteins also showed stronger correlations with the severity of vessel disease, including the LDL receptor and PECAM1, both known to influence vascular function.

Researchers then applied genetic analyses to explore whether any of these proteins had a direct causal link to developing heart attacks. The findings pointed to follistatin, PCSK9, and PECAM1 as potential drivers of disease development. These results align with known biological pathways in coronary artery disease and suggest that certain proteins could mediate inherited susceptibility independent of lifestyle factors.

This work, published in the journal Circulation: Genomic and Precision Medicine, highlights a potential protein-based signature that may help explain why individuals with a family history face a higher risk even when traditional markers appear normal. It may eventually guide earlier intervention, improved risk stratification, and better understanding of the mechanisms behind hereditary and non-hereditary coronary artery disease.

“Our results suggest that there is a specific biological pattern connected to hereditary atherosclerotic disease, which may help to explain why some people are affected despite leading a healthy lifestyle,” said Associate Professor Per Svensson, last author of the study.

Related Links:
Karolinska Institutet


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.